Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
There are currently around 200 SARS-CoV-2 candidate vaccines in preclinical and clinical trials throughout the world. The various candidates employ a range of vaccine strategies including some novel approaches. Currently, the goal is to prove that they are safe and immunogenic in humans (phase 1/2 s...
Main Authors: | Katie L. Flanagan, Emma Best, Nigel W. Crawford, Michelle Giles, Archana Koirala, Kristine Macartney, Fiona Russell, Benjamin W. Teh, Sophie CH Wen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.579250/full |
Similar Items
-
Sex-differential heterologous (non-specific) effects of vaccines: an emerging public health issue that needs to be understood and exploited
by: Katie L. Flanagan, et al.
Published: (2017-01-01) -
RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
by: Susanna Esposito, et al.
Published: (2022-04-01) -
The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review
by: Michelle L. Giles, et al.
Published: (2019-03-01) -
Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research: An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders
by: Bahaa Abu-Raya, et al.
Published: (2021-12-01) -
Targeting regulatory T cells to improve vaccine immunogenicity in early life
by: Jorjoh eNdure, et al.
Published: (2014-09-01)